Your browser doesn't support javascript.
loading
Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE Trial.
Ojji, Dike B; Cornelius, Victoria; Partington, Giles; Francis, Veronica; Pandie, Shahiemah; Smythe, Wynand; Hickman, Nicky; Barasa, Felix; Damasceno, Albertino; Dzudie, Anastase; Jones, Erika; Ingabire, Prossie Merab; Mondo, Charles; Ogah, Okechukwu; Ogola, Elijah; Sani, Mahmoud U; Shedul, Gabriel Lamkur; Shedul, Grace; Rayner, Brian; Sliwa, Karen; Poulter, Neil.
Afiliação
  • Ojji DB; Department of Medicine, Faculty of Clinical Sciences, University of Abuja/University of Abuja Teaching Hospital, Gwagwalada, Nigeria (D.B.O.).
  • Cornelius V; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, United Kingdom (V.C., G.P., N.P.).
  • Partington G; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, United Kingdom (V.C., G.P., N.P.).
  • Francis V; Clinical Research Center, Faculty of Health Sciences, University of Cape Town, South Africa (V.F., S.P., W.S., N.H.).
  • Pandie S; Clinical Research Center, Faculty of Health Sciences, University of Cape Town, South Africa (V.F., S.P., W.S., N.H.).
  • Smythe W; Clinical Research Center, Faculty of Health Sciences, University of Cape Town, South Africa (V.F., S.P., W.S., N.H.).
  • Hickman N; Clinical Research Center, Faculty of Health Sciences, University of Cape Town, South Africa (V.F., S.P., W.S., N.H.).
  • Barasa F; MOI University Hospital, Eldoret, Kenya (F.B.).
  • Damasceno A; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique (A. Damasceno).
  • Dzudie A; Douala General Hospital, Douala, Cameroon (A. Dzudie).
  • Jones E; Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa (E.J., B.R.).
  • Ingabire PM; St Francis Hospital, Nsambya, Kampala, Uganda (P.M.I., C.M.).
  • Mondo C; St Francis Hospital, Nsambya, Kampala, Uganda (P.M.I., C.M.).
  • Ogah O; Cardiology Unit, Department of Medicine, University College Hospital, Ibadan, Nigeria (O.O.).
  • Ogola E; Department of Clinical Medicine and Therapeutics, University of Nairobi, Kenya (E.O.).
  • Sani MU; Department of Medicine, Bayero University, Kano and Aminu Kano Teaching Hospital, Nigeria (M.U.S.).
  • Shedul GL; Department of Family Medicine, University of Abuja Teaching Hospital, Gwagwalada (G.L.S.).
  • Shedul G; Department of Pharmacy, University of Abuja Teaching Hospital, Gwagwalada, Nigeria (G.S.).
  • Rayner B; Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa (E.J., B.R.).
  • Sliwa K; Hatter Institute of Cardiovascular Research in Africa, Cape Town, South Africa (K.S.).
  • Poulter N; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, United Kingdom (V.C., G.P., N.P.).
Hypertension ; 79(11): 2593-2600, 2022 11.
Article em En | MEDLINE | ID: mdl-36052684
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Perindopril / Hipertensão Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Hypertension Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Perindopril / Hipertensão Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Hypertension Ano de publicação: 2022 Tipo de documento: Article